rs187204080
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_172244.3(SGCD):c.770G>A(p.Ter257Ter) variant causes a stop retained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000423 in 1,547,220 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0023 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 1 hom. )
Consequence
SGCD
NM_172244.3 stop_retained
NM_172244.3 stop_retained
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.247
Genes affected
SGCD (HGNC:10807): (sarcoglycan delta) The protein encoded by this gene is one of the four known components of the sarcoglycan complex, which is a subcomplex of the dystrophin-glycoprotein complex (DGC). DGC forms a link between the F-actin cytoskeleton and the extracellular matrix. This protein is expressed most abundantly in skeletal and cardiac muscle. Mutations in this gene have been associated with autosomal recessive limb-girdle muscular dystrophy and dilated cardiomyopathy. Alternatively spliced transcript variants encoding distinct isoforms have been observed for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 5-156757775-G-A is Benign according to our data. Variant chr5-156757775-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 48124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-156757775-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.247 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00231 (352/152320) while in subpopulation AFR AF= 0.00818 (340/41574). AF 95% confidence interval is 0.00746. There are 2 homozygotes in gnomad4. There are 152 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCD | NM_000337.6 | c.699+71G>A | intron_variant | ENST00000337851.9 | NP_000328.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCD | ENST00000337851.9 | c.699+71G>A | intron_variant | 1 | NM_000337.6 | ENSP00000338343.4 | ||||
SGCD | ENST00000435422.7 | c.696+71G>A | intron_variant | 1 | ENSP00000403003.2 | |||||
SGCD | ENST00000517913.5 | c.770G>A | p.Ter257Ter | stop_retained_variant | 10/10 | 5 | ENSP00000429378.1 |
Frequencies
GnomAD3 genomes AF: 0.00231 AC: 351AN: 152202Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
351
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000468 AC: 79AN: 168822Hom.: 1 AF XY: 0.000312 AC XY: 28AN XY: 89626
GnomAD3 exomes
AF:
AC:
79
AN:
168822
Hom.:
AF XY:
AC XY:
28
AN XY:
89626
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000217 AC: 303AN: 1394900Hom.: 1 Cov.: 31 AF XY: 0.000182 AC XY: 125AN XY: 687764
GnomAD4 exome
AF:
AC:
303
AN:
1394900
Hom.:
Cov.:
31
AF XY:
AC XY:
125
AN XY:
687764
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00231 AC: 352AN: 152320Hom.: 2 Cov.: 32 AF XY: 0.00204 AC XY: 152AN XY: 74478
GnomAD4 genome
AF:
AC:
352
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
152
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 13, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 15, 2012 | X257X in exon 8 of SGCD: This variant is not expected to have clinical significa nce because it does not alter the stop codon and is not located near a splice ju nction. This variant was present in 3.0% (10/334) of African American control ch romosomes (LMM unpublished data) and in 0.9% (33/3832) of African American chrom osomes from a broad population by the NHLBI Exome Sequencing Project (http://evs .gs.washington.edu/EVS/; dbSNP rs187204080). - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 24, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Autosomal recessive limb-girdle muscular dystrophy type 2F Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Feb 08, 2023 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2F;C1847667:Dilated cardiomyopathy 1L Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 26, 2018 | - - |
Dilated cardiomyopathy 1L Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Feb 08, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at